College Park, GA · Founded 2020 · Privately Held (backing)
Developer of antiviral medicines designed for the treatment of respiratory infections and global viral threats. Altesa BioSciences is based in College Park, GA and was founded in 2020. It was valued at $190 million at its later-stage round in Feb 2026, the last priced event on record. It has raised $114 million across 2 recorded rounds; the latest was a $75 million later-stage round in Feb 2026.
PMV mark · valuation
$190.0M
Oct 2026
Priced at
its later-stage round
Feb 2026
Total raised
$114.0M
Last round
Later Stage VC
Feb 2026
No prints on record
No secondary trades in Altesa BioSciences shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Altesa BioSciences with a free account
·Watch Altesa BioSciences: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Altesa BioSciences stock.
